Thyroid stimulating hormone reference range and prevalence of thyroid dysfunction in the Korean population: Korea National Health and Nutrition Examination Survey 2013 to 2015

Endocrinology and Metabolism

Volumn 32, Issue 1, 2017, Pages 106-114

  Kim, Won Gu ^a   Kim, Won Bae ^a   Woo, Gyeongji ^b   Kim, Hyejin ^b   Cho, Yumi ^b   Kim, Tae Yong ^a   Kim, Sun Wook ^c   Shin, Myung Hee ^c   Park, Jin Woo ^d   Park, Hai Lin ^e   Oh, Kyungwon ^b   Chung, Jae Hoon ^c  

^a University of Ulsan College of Medicine   (South Korea)

^b Korea Centers for Disease Control and Prevention   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Chungbuk National University College of Medicine   (South Korea)

^e CHA University   (South Korea)

Author keywords

Hyperthyroidism; Hypothyroidism; Prevalence; Thyroid gland; Thyrotropin

Indexed keywords

THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FREE THYROXINE INDEX; GROUPS BY AGE; HEALTH SURVEY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; KOREA; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; REFERENCE VALUE; SEX DIFFERENCE; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; THYROID DISEASE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; YOUNG ADULT;

EID: 85015831241     PISSN: 2093596X     EISSN: 20935978     Source Type: Journal    
DOI: 10.3803/EnM.2017.32.1.106     Document Type: Article

References (28)

1. Cooper DS. Subclinical hypothyroidism. JAMA 1987;258: 246-7.
2. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008;29:76-131.
3. Kim YA, Park YJ. Prevalence and risk factors of subclinical thyroid disease. Endocrinol Metab (Seoul) 2014;29:20-9.
4. Aghini-Lombardi F, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F, et al. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 1999;84:561-6.
5. Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 1998;83:765-9.
6. O'Leary PC, Feddema PH, Michelangeli VP, Leedman PJ, Chew GT, Knuiman M, et al. Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin Endocrinol (Oxf) 2006;64: 97-104.
7. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985;145:1386-8.
8. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-99.
9. Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med 1990;150:785-7.
10. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-34.
11. Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D, et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med 2006;354:2783-93.
12. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991;34:77-83.
13. Boekholdt SM, Titan SM, Wiersinga WM, Chatterjee K, Basart DC, Luben R, et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf) 2010;72:404-10.
14. Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007;92:4575-82.
15. Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE. National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab 2007;92:4236-40.
16. Cho NH, Choi HS, Kim KW, Kim HL, Lee SY, Choi SH, et al. Interaction between cigarette smoking and iodine intake and their impact on thyroid function. Clin Endocrinol (Oxf) 2010;73:264-70.
17. Guan H, Shan Z, Teng X, Li Y, Teng D, Jin Y, et al. Influence of iodine on the reference interval of TSH and the optimal interval of TSH: results of a follow-up study in areas with different iodine intakes. Clin Endocrinol (Oxf) 2008; 69:136-41.
18. Surks MI, Boucai L. Age-and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab 2010;95:496-502.
19. Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H. Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. Eur J Endocrinol 2000;143:485-91.
20. Bulow Pedersen I, Knudsen N, Jorgensen T, Perrild H, Ovesen L, Laurberg P. Large differences in incidences of overt hyper-and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. J Clin Endocrinol Metab 2002; 87:4462-9.
21. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3-126.
22. Kim M, Kim TY, Kim SH, Lee Y, Park SY, Kim HD, et al. Reference interval for thyrotropin in a ultrasonography screened Korean population. Korean J Intern Med 2015;30: 335-44.
23. Seo GH, Chung JH. Incidence and prevalence of overt hypothyroidism and causative diseases in Korea as determined using claims data provided by the Health Insurance Review and Assessment Service. Endocrinol Metab (Seoul) 2015; 30:288-96.
24. Seo GH, Kim SW, Chung JH. Incidence & prevalence of hyperthyroidism and preference for therapeutic modalities in Korea. J Korean Thyroid Assoc 2013;6:56-63.
25. Ministry of the Interior. Seegene Medical Foundation, Laboratory Medicine of the Korea National Health and Nutrition Examination Survey VI (2013-2015) [Internet]. Seoul: Centers for Disease Control and Prevention; 2015 [updated 2015 Dec 18; cited 2017 Jan 23]. Available from: http://www.prism.go.kr/homepage/ entire/retrieveEntireDetail.do?pageIndex=1&research_ id=1351000-201500293&leftMenuLevel=160&cond_research_ name=%EC%A7%84%EB%8B%A8%EC%9D%98%ED%95%99%EA%B2%80%EC%82%AC&cond_research_ start_date=&cond_research_end_date=&pageUnit=10&cond_ order=3.
26. Hollowell JG, Staehling NW, Hannon WH, Flanders DW, Gunter EW, Maberly GF, et al. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994). J Clin Endocrinol Metab 1998;83:3401-8.
27. Caldwell KL, Miller GA, Wang RY, Jain RB, Jones RL. Iodine status of the U.S. population, National Health and Nutrition Examination Survey 2003-2004. Thyroid 2008;18: 1207-14.
28. Choi HS, Park YJ, Kim HK, Choi SH, Lim S, Park DJ, et al. Prevalence of subclinical hypothyroidism in two population based-cohort: Ansung and KLoSHA cohort in Korea. J Korean Thyroid Assoc 2010;3:32-40.